Breaking News Instant updates and real-time market news.

SPHS

Sophiris Bio

$2.57

-0.06 (-2.28%)

09:16
08/29/18
08/29
09:16
08/29/18
09:16

Piper expects shares of Sophiris Bio to open 'sharply higher'

Piper Jaffray analyst Christopher Raymond expects shares of Sophiris Bio to open "sharply higher" on this morning's formal confirmation that topsalysin was not a factor in a patient death seen in the drug's Phase 2b study in patients with localized prostate cancer. In that the death "cast a pall over an otherwise positive data release, we expect the stock to react favorably this morning," Raymond tells investors in a research note. He points out that moving forward, Sophiris has indicated a Phase 3 study confirming the clinical response rate is planned likely next year. The analyst likes the set-up for topsalysin and keeps an Overweight rating on Sophiris Bio with a $7 price target. The stock in premarket trading is up 23%, or 58c, to $3.14.

SPHS Sophiris Bio
$2.57

-0.06 (-2.28%)

06/25/18
MAXM
06/25/18
NO CHANGE
MAXM
Sophiris Bio's topsalysin remains a vaible PC drug candidate, says Maxim
Maxim analyst Jason McCarthy said Buy rated Sophiris Bio shares are being pressured by a patient death, which the cause remains unknown. The analyst said the data for single administration is positive and there have bee no safety issues. McCarthy continues to believe that topsalysin remains a viable PC drug candidate, but notes we have to wait on repeat administration data later in 2018 and a report on the patient.
06/25/18
PIPR
06/25/18
NO CHANGE
Target $7
PIPR
Overweight
Piper says Sophiris Bio 'worth sticking with' despite patient death in trial
A patient death after retreatment has "placed a cloud" over Sophiris Bio's topsalysin program despite efficacy data that was "clearly a home run," according to Piper Jaffray analyst Christopher Raymond. He sees a good chance the incident may end up not being categorized as drug-related, noting that topsalysin previously had shown a "pristine safety profile," and Raymond thinks the stock is "worth sticking with" at this point. The analyst, who is reserving judgment until more detail on topsalysin's role in the death is available, thinks there remains a credible path forward even if the death is deemed drug related. He keeps an Overweight rating and $7 price target on Sophiris shares, which fell about 40% to $2.24 today.
06/26/18
PIPR
06/26/18
NO CHANGE
Target $7
PIPR
Overweight
Sophiris Bio 'worth sticking with' after patient death, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond maintained an Overweight rating and $7 price target on Sophiris Bio following disclosure of Phase 2b topsalysin data in localized prostate cancer. In a research note to investors, Raymond contended that while a patient death is "never a great headline," and that death after retreatment has now placed a cloud over the program, he thinks there is a good chance this incident may end up not being categorized as drug-related, and thinks it's worth "sticking with it here." Raymond sees a "credible" path forward with single administration, and urges investors to be patient on the name as clarity on the death and clinical path come more into focus.
08/14/18
PIPR
08/14/18
NO CHANGE
Target $7
PIPR
Overweight
Sophiris Bio topsalycin trial death disclosure imminent, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond kept his Overweight rating and $7 price target on Sophiris Bio after its "uneventful" Q2 report. The analyst says that while the company did not update on the cause of death of one of its Phase 2b topsalycin trial patients, conversations with the management suggest that the disclosure is "imminent". Raymond adds that with the cause of death being announced, the "cloud" over the program will be lifted, allowing investors to focus on the drug's "impressive efficacy".

TODAY'S FREE FLY STORIES

AEO

American Eagle

$19.03

-0.49 (-2.51%)

21:09
12/11/18
12/11
21:09
12/11/18
21:09
Recommendations
American Eagle analyst commentary at Loop Capital »

American Eagle estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

FDC

First Data

$17.50

-0.22 (-1.24%)

21:03
12/11/18
12/11
21:03
12/11/18
21:03
Hot Stocks
First Data to partner with China Citic Bank on e-commerce solutions »

First Data and Hong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 03

    Mar

LAUR

Laureate Education

$14.69

0.1 (0.69%)

20:37
12/11/18
12/11
20:37
12/11/18
20:37
Initiation
Laureate Education initiated at Citi »

Laureate Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$26.06

0.19 (0.73%)

20:35
12/11/18
12/11
20:35
12/11/18
20:35
Hot Stocks
PG&E provides investigation update related to California's Camp Fire »

Pacific Gas and Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOX

Amdocs

$60.09

0.46 (0.77%)

20:31
12/11/18
12/11
20:31
12/11/18
20:31
Recommendations
Amdocs analyst commentary at JPMorgan »

Amdocs can exceed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NICE

Nice Systems

$112.05

-0.09 (-0.08%)

20:24
12/11/18
12/11
20:24
12/11/18
20:24
Recommendations
Nice Systems analyst commentary at Jefferies »

Nice Systems set up for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

NAK

Northern Dynasty

$0.64

-0.02 (-3.03%)

20:03
12/11/18
12/11
20:03
12/11/18
20:03
Syndicate
Northern Dynasty to place 11.3M special warrants for EPA litigation costs »

Northern Dynasty Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

19:57
12/11/18
12/11
19:57
12/11/18
19:57
Periodicals
Trump: Fed would be 'foolish' to raise rates next week, Reuters says »

In an interview with…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

19:48
12/11/18
12/11
19:48
12/11/18
19:48
Periodicals
Trump may intervene in Huawei CFO arrest to get China trade deal, Reuters says »

In an interview with…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TME

Tencent Music

$0.00

(0.00%)

19:33
12/11/18
12/11
19:33
12/11/18
19:33
Syndicate
Tencent Music 82M share IPO priced at $13.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TME

Tencent Music

$0.00

(0.00%)

19:26
12/11/18
12/11
19:26
12/11/18
19:26
Syndicate
Breaking Syndicate news story on Tencent Music »

Tencent Music prices IPO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

CRM

Salesforce

$136.83

-0.46 (-0.34%)

19:25
12/11/18
12/11
19:25
12/11/18
19:25
Conference/Events
Salesforce management to meet with Goldman Sachs »

Alex Dayon, President and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 19

    Dec

  • 20

    Dec

  • 03

    Mar

O

Realty Income

$66.30

0.58 (0.88%)

19:06
12/11/18
12/11
19:06
12/11/18
19:06
Hot Stocks
Realty Income raises monthly dividend to 22.1c per share from 22.05c »

Realty Income Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKH

Black Hills

$67.28

0.06 (0.09%)

19:02
12/11/18
12/11
19:02
12/11/18
19:02
Hot Stocks
Black Hills buys 50% interest in Busch Ranch I Wind Farm »

Black Hills Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXNX

Axonics

$15.66

-0.36 (-2.25%)

, PVTL

Pivotal Software

$17.80

-0.23 (-1.28%)

18:59
12/11/18
12/11
18:59
12/11/18
18:59
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

AXNX

Axonics

$15.66

-0.36 (-2.25%)

PVTL

Pivotal Software

$17.80

-0.23 (-1.28%)

HAIN

Hain Celestial

$18.80

-0.38 (-1.98%)

URI

United Rentals

$101.89

0.02 (0.02%)

VKTX

Viking Therapeutics

$9.47

0.01 (0.11%)

FSLR

First Solar

$42.43

-0.79 (-1.83%)

JAZZ

Jazz Pharmaceuticals

$140.46

0.9 (0.64%)

SEIC

SEI Investments

$48.50

-0.64 (-1.30%)

BEN

Franklin Resources

$31.53

-0.52 (-1.62%)

PLAY

Dave & Buster's

$51.08

-1.44 (-2.74%)

AEO

American Eagle

$19.03

-0.49 (-2.51%)

ARWR

Arrowhead

$13.61

-0.05 (-0.37%)

MRNS

Marinus Pharmaceuticals

$5.10

-0.14 (-2.67%)

FLDM

Fluidigm

$7.58

-0.11 (-1.43%)

TOCA

Tocagen

$12.85

0.2 (1.58%)

LAND

Gladstone Land

$13.33

-0.16 (-1.19%)

ANGI

Angi Homeservices

$16.62

-0.11 (-0.66%)

BAC

Bank of America

$24.58

-0.17 (-0.69%)

MS

Morgan Stanley

$40.62

-0.07 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 14

    Dec

  • 19

    Dec

  • 20

    Dec

  • 20

    Dec

  • 12

    Feb

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

, BSX

Boston Scientific

$36.55

0.41 (1.13%)

18:47
12/11/18
12/11
18:47
12/11/18
18:47
Hot Stocks
Edwards says does not expect to pay $35M award in Boston Scientific case »

Edwards Lifesciences (EW)…

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

BSX

Boston Scientific

$36.55

0.41 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RARX

RA Pharmaceuticals

$15.97

-1.61 (-9.16%)

18:41
12/11/18
12/11
18:41
12/11/18
18:41
Syndicate
RA Pharmaceuticals 8.4M share Secondary priced at $15.50 »

Jefferies, BMO Capital,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

HTLF

Heartland Financial

$49.30

-0.24 (-0.48%)

18:38
12/11/18
12/11
18:38
12/11/18
18:38
Hot Stocks
Heartland Financial announces special cash dividend of 5c »

Heartland Financial USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANGI

Angi Homeservices

$16.62

-0.11 (-0.66%)

18:24
12/11/18
12/11
18:24
12/11/18
18:24
Syndicate
Angi Homeservices 1.5M share Spot Secondary priced at $16.40 »

The deal priced within…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

18:24
12/11/18
12/11
18:24
12/11/18
18:24
Periodicals
Huawei CFO Meng granted bail by Canadian judge, Bloomberg reports »

Huawei Technologies Co.…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.55

0.41 (1.13%)

, EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

18:14
12/11/18
12/11
18:14
12/11/18
18:14
Hot Stocks
Boston Scientific says it 'prevails' in U.S. Edwards Lifesciences litigation »

Boston Scientific (BSX)…

BSX

Boston Scientific

$36.55

0.41 (1.13%)

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

MSFT

Microsoft

$108.67

1.11 (1.03%)

18:14
12/11/18
12/11
18:14
12/11/18
18:14
Hot Stocks
Microsoft CMO Chris Capossela sells 4K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GLD

SPDR Gold Shares

$117.55

-0.13 (-0.11%)

18:05
12/11/18
12/11
18:05
12/11/18
18:05
Hot Stocks
SPDR Gold Shares holdings rise to 763.56MT from 760.32MT »

This is the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

18:04
12/11/18
12/11
18:04
12/11/18
18:04
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

Huawei CFO Meng granted…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIEGY

Siemens

$0.00

(0.00%)

17:56
12/11/18
12/11
17:56
12/11/18
17:56
Periodicals
Siemens to close Texas turbines facility, dismiss 200 workers, Reuters says »

Siemens intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.